Myszkowski Kenneth Allen
Arrowhead Pharmaceuticals Inc · Chief Financial Officer
Myszkowski Kenneth Allen is listed in filings as Chief Financial Officer at Arrowhead Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Jan 7, 2025, including sale activity. Recent filings connect the profile to Arrowhead Pharmaceuticals Inc (ARWR). The current snapshot covers public activity from Jan 7, 2025. Reported amounts are shown as $196.9K to $349.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $350k17.8k shares | SellJan 6, 2025 | $19.68 | $71.38 | |
| $189k9.4k shares | SellJan 6, 2025 | $20.10 | $71.38 |